CDNA
CareDx Inc
NASDAQ: CDNA · HEALTHCARE · DIAGNOSTICS & RESEARCH
$20.81
+0.05% today
Updated 2026-04-30
Market cap
$1.09B
P/E ratio
—
P/S ratio
2.86x
EPS (TTM)
$-0.40
Dividend yield
—
52W range
$11 – $23
Volume
0.7M
CareDx Inc (CDNA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-5.62%
Operating margin
-3.49%
ROE
-6.27%
ROA
-3.15%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $20.45M | $-5.06M | 61.22% | -11.45% | -24.74% |
| 2013 | $22.10M | $-3.54M | 58.92% | -3.88% | -16.03% |
| 2014 | $27.31M | $781000.00 | 68.72% | 4.58% | 2.86% |
| 2015 | $28.14M | $-13.71M | 63.50% | -42.40% | -48.70% |
| 2016 | $40.63M | $-39.47M | 48.02% | -91.88% | -97.14% |
| 2017 | $48.32M | $-55.47M | 55.78% | -42.00% | -114.79% |
| 2018 | $76.57M | $-46.76M | 56.92% | -20.35% | -61.06% |
| 2019 | $127.07M | $-21.97M | 64.23% | -19.31% | -17.29% |
| 2020 | $192.19M | $-18.71M | 67.16% | -11.72% | -9.74% |
| 2021 | $296.40M | $-30.66M | 67.14% | -10.03% | -10.34% |
| 2022 | $321.79M | $-76.61M | 65.13% | -24.00% | -23.81% |
| 2023 | $280.32M | $-190.28M | 63.61% | -72.55% | -67.88% |
| 2024 | $333.79M | $52.55M | 67.16% | 12.21% | 15.74% |
| 2025 | $379.81M | $-21.35M | 66.99% | -5.53% | -5.62% |